GTP offers a diversity of expression strategies from transient expression to stable cell line development. Our expert scientists have over 19 years of experience producing recombinant proteins and antibodies in mammalian cells.
In most cases, mammalian cells are the optimal system to produce recombinant mammalian proteins. Their capacity for proper protein folding, for post-translational modifications, and for protein assembly are crucial to biological activity.
The GTP team has sucessfully expressed a variety of recombinant proteins, monoclonal antibodies as well as antibody fragments in mammalian expression systems.
GTP's expertise in mammalian systems is directly linked to our longstanding experience with monoclonal antibodies and antibody fragments for therapeutic development programmes , virus-like particles for vaccine development, membrane target proteins for research studies…
Our expert scientists have developed an efficient transient transfection platform in either CHO or HEK cells allowing the production of protein quantities ranging from micrograms to grams.
Thanks to our optimized expression conditions, we routinely achieve high expression yields for a variety of proteins, human or mouse antibodies.